Barclays analyst Stephanie Davis raised the firm’s price target on Labcorp (LH) to $249 from $234 and keeps an Equal Weight rating on the shares post the Q3 report. The firm says Labcorp could be a beneficiary of the need for relative safety in healthcare services into year-end.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LH:
- Morning Movers: UPS ascends and Textron descends after quarterly reports
- Labcorp reports Q3 adjusted EPS $3.50, consensus $3.48
- Labcorp narrows FY24 adjusted EPS view to $14.30-$14.70 from $14.30-$14.90
- Notable companies reporting before tomorrow’s open
- Activist Corvex acquires stake in Fortrea Holdings, Bloomberg reports